Publications by authors named "Helena Linardou"

Claim this Profile
M
Molecular Tumor Boards: A Consensus Statement From the International Association for the Study of Lung Cancer.
Mihaela Aldea, Julia K Rotow, Maria Arcila, Matthew Hatton, Lynette Sholl, Helena Linardou

J Thorac Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LEAP-008: Lenvatinib Plus Pembrolizumab for Metastatic NSCLC That Has Progressed After an Anti-Programmed Cell Death Protein 1 or Anti-Programmed Cell Death Ligand 1 Plus Platinum Chemotherapy.
Natasha B Leighl, Luis Paz-Ares, Delvys Rodriguez Abreu, Rina Hui, Sofia Baka, Helena Linardou

J Thorac Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intercalated Avelumab plus platinum-based chemotherapy in patients with Extensive-Stage Small-Cell Lung cancer (PAVE): Final outcome, immunophenotypic and biomarker analysis of a multi-center phase II Hellenic Cooperative Oncology Group study.
Helena Linardou, Kyriaki Papadopoulou, Nikolaos Korfiatis, Anna Goussia, Epaminondas Samantas

Eur J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adagrasib versus docetaxel in KRAS-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial.
Fabrice Barlesi, Wenxiu Yao, Michaël Duruisseaux, Ludovic Doucet, Aitor Azkárate Martínez, Helena Linardou

Lancet· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection rate for ESR1 mutations is higher in circulating-tumor-cell-derived genomic DNA than in paired plasma cell-free DNA samples as revealed by ddPCR.
Stavroula Smilkou, Aliki Ntzifa, Victoria Tserpeli, Ioanna Balgkouranidou, Alkistis Papatheodoridi, Helena Linardou

Mol Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA).
Francesco Passiglia, Angela Listì, Paolo Bironzo, Alessandra Merlini, Federica Benso, Helena Linardou

J Thorac Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sotorasib versus docetaxel for previously treated KRAS G12C-mutated non-small-cell lung cancer: a plain language summary.
Adrianus Johannes de Langen, Melissa L Johnson, Julien Mazieres, Anne-Marie C Dingemans, Giannis Mountzios, Helena Linardou

Future Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns in patients with non-metastatic non-small cell lung cancer in Greece: the 'EVIDENCE' study.
Giannis Mountzios, Sofia Lampaki, Helena Linardou, Vassilis Georgoulias, Dimitrios Mavroudis

Future Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct comparison of an ultrasensitive real-time PCR assay with droplet digital PCR for the detection of hotspot mutations in primary tumors, plasma cell-free DNA and paired CTC-derived gDNAs.
Stavroula Smilkou, Loukas Kaklamanis, Ioanna Balgouranidou, Helena Linardou, Alkistis Maria Papatheodoridi

Front Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The active involvement of patients in oncology research.
Ursula Ganz-Blaettler, Sarah Jayne Liptrott, Angela Tolotti, Marco Cefalì, Christine Aeschlimann, Helena Linardou

Cancer Treat Rev· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients.
Antonis Valachis, Laura Biganzoli, Athina Christopoulou, Kamilla Fjermeros, Elena Fountzila, Helena Linardou

Future Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation.
David M Waterhouse, Sacha Rothschild, Christophe Dooms, Bertrand Mennecier, Farastuk Bozorgmehr, Helena Linardou

Lung Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1.
Martin Reck, Tudor-Eliade Ciuleanu, Jong-Seok Lee, Michael Schenker, Bogdan Zurawski, Helena Linardou

J Thorac Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Use of a Digital Platform for Cancer Patients to Report Their Demographics, Disease and Therapy Characteristics, Age, and Educational Disparities: An Early-Stage Feasibility Study.
Dimitra Galiti, Helena Linardou, Sofia Agelaki, Athanasios Karampeazis, Nikolaos Tsoukalas

Curr Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The EU-funded ILUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy.
Arsela Prelaj, Monica Ganzinelli, Francesco Trovo', Laila C Roisman, Alessandra Laura Giulia Pedrocchi, Helena Linardou

Clin Lung Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Data and Economic Evaluation of Nivolumab in Previously Treated Non-small Cell Lung Cancer Greek Patients.
Helena Linardou, Sofia Lampaki, Georgia-Angeliki Koliou, Athanassios Vozikis, Anastasios Boutis

Anticancer Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes Beyond 1L -TKI Progression in mNSCLC: Final Results of the Real-World Study 'LUNGFUL'.
Giannis Mountzios, Anna Koumarianou, Helena Linardou, Anastasios Boutis, Dimitrios Mavroudis

Anticancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS mutation: a randomised, open-label, phase 3 trial.
Adrianus Johannes de Langen, Melissa L Johnson, Julien Mazieres, Anne-Marie C Dingemans, Giannis Mountzios, Helena Linardou

Lancet· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817.
Neal E Ready, Clarisse Audigier-Valette, Jonathan W Goldman, Enriqueta Felip, Tudor-Eliade Ciuleanu, Helena Linardou

J Immunother Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817.
Luis G Paz-Ares, Tudor-Eliade Ciuleanu, Adam Pluzanski, Jong-Seok Lee, Justin F Gainor, Helena Linardou

J Thorac Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry.
Giannis Mountzios, David Planchard, Giulio Metro, Dora Tsiouda, Arsela Prelaj, Helena Linardou

JTO Clin Res Rep· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Predisposition to Male Breast Cancer: A Case Series.
Angela Apessos, Konstantinos Agiannitopoulos, Georgia Pepe, Georgios N Tsaousis, Panagiota Pitta, Helena Linardou

Anticancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Cancer Screening in Greece: A Modelling Study to Estimate the Impact on Lung Cancer Life Years.
Kyriakos Souliotis, Christina Golna, Pavlos Golnas, Ioannis-Anestis Markakis, Helena Linardou

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy-A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study.
Nikolaos Spathas, Anna C Goussia, Georgia-Angeliki Koliou, Helen Gogas, Flora Zagouri, Helena Linardou

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Ophthalmological Side Effects Induced by Anti-Neoplastic Regimens for the Treatment of Genitourinary Cancers: A Review.
Minas Sakellakis, Nikolaos Spathas, Konstantinos T Tsaousis, Emmanouil N Nikitiadis, Helena Linardou

Cureus· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis